Back

Patiromer use for the treatment of hyperkaliemia in patients with heart failure and chronic kidney disease, real-world experience

18 May 2025 (15:40 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - comorbidities (5) Comorbidities HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Luca Grau Torrente

Coast of the sun Hospital, Marbella (Spain)

5 More presentations in this session

Presentation thumbnail
Biomarkers related to heart failure as predictors of incident stroke in the general population
Doctor N. Suthahar (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Impact of ferric carboxymaltose on left ventricular ejection fraction in iron-deficient heart failure patients of south asian descent
Doctor D. Abousaid (Hyderabad, IN)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation with rapid ventricular response in acute decompensated heart failure
Professor D. Aronson (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Association between high sensitivity C-reactive protein and neutrophil to lymphocyte ratio with frailty syndrome in heart failure with reduced ejection fraction.
Miss A. Szubarga (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
The prognostic significance of iron deficiency in hospitalized heart failure patients
Miss X. Zhao (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - comorbidities (5)

The Event

Event poster

Heart Failure 2025

18 May 2025 15:40 CET
You may be interested in
thumbnail
Congress Presentation
Clinical practice associated with 6-month use of patiromer in patients with heart failure
13 May 2024
thumbnail
Congress Presentation
A practical model for optimising RAASi-based therapy
26 August 2023
thumbnail
Congress Presentation
Hyperkalemia, clinical outcomes, and mineralocorticoid receptor antagonist in heart failure: insights from the REVIEW-HF registry
9 May 2026
thumbnail
Congress Presentation
Hyperkalemia events in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan or sodium-glucose transport protein 2 inhibitors: a single-center experience
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources